Prognostic and clinicopathological impacts of systemic immune-inflammation index on patients with diffuse large B-cell lymphoma: a meta-analysis
Background: The systemic immune-inflammation index (SII) represents the immunoinflammatory score and can be considered as a prognostic marker; however, its relevance to the prognosis in patients with diffuse large B-cell lymphoma (DLBCL) remains unclear. Objectives: The present meta-analysis was con...
Main Authors: | Zaijing Fan, Lihong Shou |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-11-01
|
Series: | Therapeutic Advances in Hematology |
Online Access: | https://doi.org/10.1177/20406207231208973 |
Similar Items
-
Prognostic and clinicopathological role of geriatric nutritional risk index in patients with diffuse large B-cell lymphoma: A meta-analysis
by: Dan Cao, et al.
Published: (2023-03-01) -
Prognostic and clinicopathological significance of the Controlling Nutritional Status (CONUT) score in patients with lymphoma: a meta-analysis
by: Lili Li, et al.
Published: (2024-03-01) -
Prognostic evaluation of system immune-inflammatory index and prognostic nutritional index in double expressor diffuse large B-cell lymphoma
by: Su Fang, et al.
Published: (2023-10-01) -
Clinicopathologic characteristics, gene mutation profile and prognostic analysis of thyroid diffuse large B-cell lymphoma
by: DU Zhishan, et al.
Published: (2024-01-01) -
Does Systemic Immune Inflammation Index Predicts Survival In Diffuse Large B Cell Lymphoma Patients?
by: Murat Albayrak, et al.
Published: (2023-10-01)